Literature DB >> 10477314

Role of alpha(v) integrins in adenovirus cell entry and gene delivery.

G R Nemerow1, P L Stewart.   

Abstract

Adenoviruses (Ad) are a significant cause of acute infections in humans; however, replication-defective forms of this virus are currently under investigation for human gene therapy. Approximately 20 to 25% of all the gene therapy trials (phases I to III) conducted over the past 10 years involve the use of Ad gene delivery for treatment inherited or acquired diseases. At present, the most promising applications involve the use of Ad vectors to irradicate certain nonmetastatic tumors and to promote angiogenesis in order to alleviate cardiovascular disease. While specific problems of using Ad vectors remain to be overcome (as is true for almost all viral and nonviral delivery methods), a distinct advantage of Ad is the extensive knowledge of its macromolecular structure, genome organization, sequence, and mode of replication. Moreover, significant information has also been acquired on the interaction of Ad particles with distinct host cell receptors, events which strongly affect virus tropism. This review provides an overview of the structure and function of Ad attachment (coxsackievirus and Ad receptor [CAR]) and internalization (alpha(v) integrins) receptors and discusses their precise role in virus infection and gene delivery. Recent structure studies of integrin-Ad complexes by cryoelectron microscopy are also highlighted. Finally, unanswered questions arising from the current state of knowledge of Ad-receptor interactions are presented in the context of improving Ad vectors for future human gene therapy applications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477314      PMCID: PMC103752          DOI: 10.1128/MMBR.63.3.725-734.1999

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  103 in total

1.  Structure of adenovirus complexed with its internalization receptor, alphavbeta5 integrin.

Authors:  C Y Chiu; P Mathias; G R Nemerow; P L Stewart
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells.

Authors:  C Lamaze; L M Fujimoto; H L Yin; S L Schmid
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

3.  Adenovirus infection in pediatric liver transplant recipients.

Authors:  M G Michaels; M Green; E R Wald; T E Starzl
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

4.  Targeted adenovirus-mediated gene delivery to T cells via CD3.

Authors:  T J Wickham; G M Lee; J A Titus; G Sconocchia; T Bakács; I Kovesdi; D M Segal
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Pervasive conformational fluctuations on microsecond time scales in a fibronectin type III domain.

Authors:  M Akke; J Liu; J Cavanagh; H P Erickson; A G Palmer
Journal:  Nat Struct Biol       Date:  1998-01

6.  Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate alpha v integrin expression on cultured human macrophages.

Authors:  M O De Nichilo; G F Burns
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

7.  Infectious entry pathway of adenovirus type 2.

Authors:  M J Varga; C Weibull; E Everitt
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.

Authors:  I Dmitriev; V Krasnykh; C R Miller; M Wang; E Kashentseva; G Mikheeva; N Belousova; D T Curiel
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Spliced segments at the 5' terminus of adenovirus 2 late mRNA.

Authors:  S M Berget; C Moore; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization.

Authors:  T J Wickham; E J Filardo; D A Cheresh; G R Nemerow
Journal:  J Cell Biol       Date:  1994-10       Impact factor: 10.539

View more
  92 in total

1.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions.

Authors:  D A Einfeld; R Schroeder; P W Roelvink; A Lizonova; C R King; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 3.  Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction.

Authors:  Vincent Hurez; Robin D Hautton; James Oliver; R James Matthews; Casey K Weaver
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  A new mutant class, made by targeted mutagenesis, of phage PRD1 reveals that protein P5 connects the receptor binding protein to the vertex.

Authors:  J K Bamford; D H Bamford
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells.

Authors:  Y Y Wan; R P Leon; R Marks; C M Cham; J Schaack; T F Gajewski; J DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

6.  Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5.

Authors:  Barbara Salone; Yuri Martina; Stefania Piersanti; Enrico Cundari; Gioia Cherubini; Laure Franqueville; Cristina M Failla; Pierre Boulanger; Isabella Saggio
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 7.  Gene therapy for urologic cancer.

Authors:  Fernando A Ferrer; Ronald Rodriguez
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 3.092

8.  A capsid protein of nonenveloped Bluetongue virus exhibits membrane fusion activity.

Authors:  Mario Forzan; Christoph Wirblich; Polly Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

9.  Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals.

Authors:  Harald Wodrich; Tinglu Guan; Gino Cingolani; Dan Von Seggern; Glen Nemerow; Larry Gerace
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

Review 10.  Homotrimeric, beta-stranded viral adhesins and tail proteins.

Authors:  Peter R Weigele; Eben Scanlon; Jonathan King
Journal:  J Bacteriol       Date:  2003-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.